QQ客服 官方微博 反馈留言

	Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells
	Wu, Mingqing; Sheng, Lu; Cheng, Maosheng; Zhang, Haojie; Jiang, Yizhou; Lin, Shuibin; Liang, Yu; Zhu, Fengyu; Liu, Zhenqing; Zhang, Yingyin
刊名	ONCOGENE
	2019
卷号	38期号:27
ISSN号	0950-9232
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3597058
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Wu, Mingqing,Sheng, Lu,Cheng, Maosheng,et al. Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells[J]. ONCOGENE,2019,38(27).
APA	Wu, Mingqing.,Sheng, Lu.,Cheng, Maosheng.,Zhang, Haojie.,Jiang, Yizhou.,...&Li, Yang.(2019).Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells.ONCOGENE,38(27).
MLA	Wu, Mingqing,et al."Low doses of decitabine improve the chemotherapy efficacy against basal-like bladder cancer by targeting cancer stem cells".ONCOGENE 38.27(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。